Liang Zhang
Lawyers
Filters
Deciphera Pharmaceuticals $135.1 million common stock offering
The common stock is listed on the Nasdaq Global Select Market
Priveterra Acquisition initial business combination with AEON Biopharma
We are advising Priveterra on the transaction
Numerix acquisition by GenStar Capital
We advised Numerix on the transaction
CSX $2 billion senior notes offering
We advised CSX on the investment-grade debt offering
Hilltop Holdings cash tender offer for stock
The company’s shares are traded on the NYSE
Province of Ontario $2.25 billion global bond offering
The bonds are due 2027
Hayward Holdings $348 million secondary offering
The stock is listed on the New York Stock Exchange
Acutus Medical sale of its left-heart access portfolio products
We are advising Acutus Medical on the transaction
Charles River Laboratories $295 million acquisition of Explora BioLabs Holdings
We advised Charles River on the transaction
Advance Auto Parts $350 million notes offering
The company issued investment-grade notes due 2032